Matrix metalloproteinases in cerebrovascular diseases

被引：52

作者：

Fatar, M ^{[1
]}

Stroick, M ^{[1
]}

Griebe, M ^{[1
]}

Hennerici, M ^{[1
]}

机构：

[1] Heidelberg Univ, Klinikum Mannheim, Dept Neurol, DE-68135 Mannheim, Germany

来源：

CEREBROVASCULAR DISEASES | 2005年 / 20卷 / 03期

关键词：

stroke; carotid artery stenosis; vascular dementia; intracranial haemorrhage; aneurysm; matrix metalloproteinases;

D O I：

10.1159/000087197

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Matrix metalloproteinases are important factors for tissue remodelling and are activated during several physiological and pathological conditions, including cerebrovascular diseases. We give an overview of the structure, production and physiological effects of these widely distributed proteases and describe the genetic background and regulation pathways. In particular, we discuss the role of matrix metalloproteinases in vascular remodelling concerning ischaemic stroke, brain haemorrhage, vascular dementia, carotid artery plaques and cerebral aneurysms. Copyright (C) 2005 S. Karger AG, Basel.

引用

页码：141 / 151

页数：11

共 124 条

[1] Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease [J].

Adair, JC ;

Charlie, J ;

Dencoff, JE ;

Kaye, JA ;

Quinn, JF ;

Camicioli, RM ;

Stetler-Stevenson, WG ;

Rosenberg, GA .

STROKE, 2004, 35 (06) :E159-E162

[2] Alterations in glia and axons in the brains of Binswanger's disease patients [J].

Akiguchi, I ;

Tomimoto, H ;

Suenaga, T ;

Wakita, H ;

Budka, H .

STROKE, 1997, 28 (07) :1423-1429

[3] Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage -: Relationship to clinical and radiological outcome [J].

Alvarez-Sabín, J ;

Delgado, P ;

Abilleira, S ;

Molina, CA ;

Arenillas, J ;

Ribó, M ;

Santamarina, E ;

Quintana, M ;

Monasterio, J ;

Montaner, J .

STROKE, 2004, 35 (06) :1316-1322

[4] Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke [J].

Anthony, DC ;

Ferguson, B ;

Matyzak, MK ;

Miller, KM ;

Esiri, MM ;

Perry, VH .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) :406-415

[5]

APODACA G, 1990, CANCER RES, V50, P2322

[6] Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia [J].

Asahi, M ;

Wang, XY ;

Mori, T ;

Sumii, T ;

Jung, JC ;

Moskowitz, MA ;

Fini, ME ;

Lo, EH .

JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7724-7732

[7] Role for matrix metalloproteinase 9 after focal cerebral ischemia, effects of gene knockout and enzyme inhibition with BB-94 [J].

Asahi, M ;

Asahi, K ;

Jung, JC ;

del Zoppo, GJ ;

Fini, ME ;

Lo, EH .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (12) :1681-1689

[8] Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].

Atkinson, SJ ;

Crabbe, T ;

Cowell, S ;

Ward, RV ;

Butler, MJ ;

Sato, H ;

Seiki, M ;

Reynolds, JJ ;

Murphy, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485

[9] Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives [J].

Beaudeux, JL ;

Giral, P ;

Bruckert, E ;

Foglietti, MJ ;

Chapman, MJ .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) :121-131

[10] Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease [J].

Blankenberg, S ;

Rupprecht, HJ ;

Poirier, O ;

Bickel, C ;

Smieja, M ;

Hafner, G ;

Meyer, J ;

Cambien, F ;

Tiret, L .

CIRCULATION, 2003, 107 (12) :1579-1585

← 1 2 3 4 5 6 7 8 9 10 →